Edition:
India

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

10.20CNY
16 Aug 2019
Change (% chg)

¥-0.01 (-0.10%)
Prev Close
¥10.21
Open
¥10.17
Day's High
¥10.34
Day's Low
¥10.13
Volume
7,010,162
Avg. Vol
12,478,058
52-wk High
¥14.15
52-wk Low
¥8.35

Latest Key Developments (Source: Significant Developments)

Humanwell Healthcare Swings To Net Loss Of 2.36 Bln Yuan In 2019
Monday, 29 Apr 2019 

April 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS 2018 NET LOSS OF 2.36 BILLION YUAN ($350.61 million) VERSUS NET PROFIT OF 2.07 BILLION YUAN YEAR EARLIER.  Full Article

BRIEF-Humanwell Healthcare Expects to Swing To Net Loss In 2018
Tuesday, 29 Jan 2019 

Refiles with additional bullet points, links:SAYS IT SEES 2018 NET LOSS OF 2.2-2.7 BILLION YUAN VERSUS NET PROFIT OF 2.1 BILLION YUAN ($311.81 million) YEAR EARLIER.SAYS IT SETS ASIDE PROVISIONS OF ASSETS IMPAIRMENT FOR ABOUT 3.0 BILLION YUAN.SAYS IT PLANS TO ISSUE BONDS WORTH UP TO 1.5 BILLION YUAN, MEDIUM-TERM NOTES WORTH UP TO 1.5 BILLION YUAN.  Full Article

Humanwell Healthcare Says H1 Net Profit Up 33.5 Percent Y/Y
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS H1 NET PROFIT UP 33.5 PERCENT Y/Y.  Full Article

Humanwell Healthcare Group unit passes FDA approval
Thursday, 5 Jul 2018 

July 5 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says a wholly owned unit Epic Pharma, LLC received approval for its drug Oxycodone and Acetaminophen Tablet from U.S Food and Drug Administration .The unit will be able to produce and sell drug Oxycodone and Acetaminophen Tablet in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare Group revises FY 2017 net profit
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it revises FY2017 net profit .Says it sees net profit for FY 2017 to increase by 144 percent to 150 percent.Says the net profit of FY 2016 was 832 million yuan .  Full Article

Humanwell Healthcare Group unit passes FDA approval
Tuesday, 20 Mar 2018 

March 20(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says its 72 percent-owned unit Puracap Pharmaceutical LLC received approval for its Naproxen Sodium Capsule from U.S Food and Drug Administration .  Full Article

Humanwell Healthcare Group sells bio-pharma firm for 350 mln yuan
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it sold 100 percent stake in Yichang-based bio-pharma firm for 350 million yuan .  Full Article

Humanwell Healthcare's Unit To Boost Capital Of Lifestyles Healthcare
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS UNIT SIGNS AGREEMENT TO BOOST CAPITAL OF LIFESTYLES HEALTHCARE PTE WITH HEALTH PRODUCTS FIRM'S 59 PERCENT STAKE WORTH $131.1 MILLION.  Full Article

Humanwell Healthcare Group completes investment in unit RFSW Investment Pte Ltd
Friday, 15 Dec 2017 

Dec 15 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says it invested 805.4 million yuan in wholly owned Singapore unit RFSW Investment Pte. Ltd.Jissbon, a Wuhan-based commodities company, becomes controlling subsidiary of RFSW Investment Pte. Ltd after equity investment .  Full Article

Humanwell Healthcare Group unit gets approval of clinical trial for Meisuoshuli tablets
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::Says its Wuhan-based unit gets approval of clinical trial for Meisuoshuli tablets, which is used for anti-inflammatory, analgesic and antipyretic .  Full Article